UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes

Ross J Mason¹, Karim Marzouk², Antonio Finelli³, Fred Saad⁴, Alan I So⁵, Phillipe D Violette^{6

7}, Rodney H Breau⁸, Ricardo A Rendon¹

Affiliations

¹ Department of Urology, Dalhousie University, Halifax, NS, Canada.
² Windsor General Hospital, Windsor, ON; and Western University, London, ON, Canada.
³ Division of Urology, University of Toronto, Toronto, ON, Canada.
⁴ Department of Surgery (Urology), University of Montreal, Montreal, QC, Canada.
⁵ Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
⁶ Department of Surgery, Western University, London, ON, Canada.
⁷ Departments of Surgery and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
⁸ Division of Urology, University of Ottawa, Ottawa, ON, Canada.

PMID: 35358410
PMCID: PMC9054326
DOI: 10.5489/cuaj.7832

UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes

Ross J Mason et al. Can Urol Assoc J. 2022 Apr.

. 2022 Apr;16(4):86-87.

doi: 10.5489/cuaj.7832.

Authors

Ross J Mason¹, Karim Marzouk², Antonio Finelli³, Fred Saad⁴, Alan I So⁵, Phillipe D Violette^{6

7}, Rodney H Breau⁸, Ricardo A Rendon¹

Affiliations

¹ Department of Urology, Dalhousie University, Halifax, NS, Canada.
² Windsor General Hospital, Windsor, ON; and Western University, London, ON, Canada.
³ Division of Urology, University of Toronto, Toronto, ON, Canada.
⁴ Department of Surgery (Urology), University of Montreal, Montreal, QC, Canada.
⁵ Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
⁶ Department of Surgery, Western University, London, ON, Canada.
⁷ Departments of Surgery and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
⁸ Division of Urology, University of Ottawa, Ottawa, ON, Canada.

PMID: 35358410
PMCID: PMC9054326
DOI: 10.5489/cuaj.7832

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. Mason has participated in advisory boards and has been a speaker for Abbvie, Sanofi, TerSera, and Verity. Dr. Saad has received honoraria from Astellas, AstraZeneca, Bayer, Janssen, Knight, Myovant, Novartis, Sanofi, and Pfizer. Dr. So has participated in advisory boards for Abbvie, Amgen, Bayer, Ferring, Janssen, Merck, and TerSera. Dr. Rendon has participated in advisory boards for Abbvie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Janssen, Pfizer, Roche, Sanofi, and Tolmar; has been a speaker for Abbvie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Janssen, Pfizer, Roche, and Sanofi; has received grants and/or honoraria from Abbvie, Astellas, Bayer, Ferring, Janssen, Sanofi, Tolmar, and TerSera; holds investments in Myovant; and has participated in clinical trials supported by Abbvie, Astellas, Bavarian Nordic, Bayer, Ferring, Janssen, Myovant, and Sanofi. The remaining authors do not report any competing personal or financial interests related to this work.

References

1. Rendon RA, Mason RJ, Marzouk K, et al. Canadian Urological Association recommendations on prostate cancer screening and early diagnosis. Can Urol Assoc J. 2017;11:298–309. doi: 10.5489/cuaj.4888. - DOI - PMC - PubMed
1. Haider MA, Brown J, Chin JLK, et al. Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A Cancer Care Ontario updated clinical practice guideline. Can Urol Assoc J. 2022;16:16–23. doi: 10.5489/cuaj.7425. - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes

Affiliations

UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes

Authors

Affiliations

Conflict of interest statement

References

LinkOut - more resources

Full Text Sources